5 insiders reported 11 Form 4 transactions for ENDRA Life Sciences Inc. (NDRA) over the past 18 months (most recent 2026-03-04). Recent activity: Jacroux Richard (Chief Financial Officer) Buy 13,461 shares, Tokman Alexander Y (Chief Executive Officer) Buy 26,921 shares, Harsh Michael (Director) Buy 60,324 shares, Basenese Lou (Director) Buy 60,324 shares, Tokman Alexander Y (Chief Executive Officer) Buy 75,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-04 | Jacroux Richard | Chief Financial Officer | Buy | 13,461 | $0 |
| 2026-03-04 | Tokman Alexander Y | Chief Executive Officer | Buy | 26,921 | $0 |
| 2026-01-23 | Harsh Michael | Director | Buy | 60,324 | $0 |
| 2026-01-23 | Basenese Lou | Director | Buy | 60,324 | $0 |
| 2026-01-23 | Tokman Alexander Y | Chief Executive Officer | Buy | 75,000 | $0 |
| 2026-01-23 | Jacroux Richard | Chief Financial Officer | Buy | 20,000 | $0 |
| 2026-01-23 | DIGIANDOMENICO ANTHONY | Director | Buy | 60,324 | $0 |
| 2025-10-15 | DIGIANDOMENICO ANTHONY | Director | Buy | 70,822 | $500,003 |
| 2025-07-01 | Basenese Lou | Director | Buy | 5,384 | $0 |
| 2025-07-01 | Harsh Michael | Director | Buy | 5,384 | $0 |
| 2025-07-01 | DIGIANDOMENICO ANTHONY | Director | Buy | 5,384 | $0 |
Source: SEC Form 4 filings · as of 2026-03-04